4DMedical Limited (ASX:4DX) Signs Commercial Agreement with Qscan
4DMedical Limited (ASX:4DX) has entered a commercial agreement with Qscan, expanding its respiratory imaging solutions in Australia.

4DMedical Limited (ASX:4DX) has entered a commercial agreement with Qscan, expanding its respiratory imaging solutions in Australia.
Poseidon Nickel Limited (ASX:POS) reports on its proposed merger with Horizon Minerals and positive exploration outcomes.
Paradigm Biopharmaceuticals receives $6.3 million R&D Tax Incentive, enhancing its Phase 3 osteoarthritis clinical trial cash reserves.
SomnoMed Limited reported a 19.8% increase in Q2 revenue, updated FY25 guidance, and welcomed a new Director amidst ongoing product development efforts.
SomnoMed Limited (ASX:SOM) reports a positive cash flow of $1.525 million for the current quarter, showcasing strong operational performance.
Pacific Smiles Group updates on strong trading performance and announces a transition in its CFO role.
Biome Australia Limited expands its distribution to over 6000 locations, achieving significant growth in the Australian health market.
Bioxyne Limited (ASX:BXN) has upgraded its revenue forecast for FY2025 to $25 million, following strong business growth and strategic expansion.
Godolphin Resources (ASX:GRL) reports strong drilling results and financial achievements as it advances its multi-commodity projects.
Neometals Ltd (ASX:NMT) announces strong financial results and significant advancements in battery recycling technologies.